Seegene Inc
상단으로
Contact Us

Not Available for sale in the United States

  • Real-time
    PCR
  • CE-IVD
    marked

Allplex™
SARS-CoV-2 Variants I Assay

Simultaneous detection and differentiation of SARS-CoV-2 and three mutation sites in S gene for identification of SARS-CoV-2 variants

Allplex™ SARS-CoV-2 Variants I Assay is a multiplex real-time PCR assay that detects and identifies three notable mutation sites in S gene including HV69/70 deletion, E484K and N501Y and highly conserved region in RdRP gene in one tube.

Key Features and Benefits

  • Multiplex real-time PCR

    Accurate multiplex test for detection and identification of SARS-CoV-2 and 3 S gene mutations in a single tube

  • Short TAT

    Results within 2 hours after extraction

  • Variant surveillance

    Monitoring the most reported SARS-CoV-2 variants of concern for efficient infection control

  • User-friendly workflow

    Convenient workflow using Seegene’s automated one platform

  • Automatic data analyzer

    Automated data interpretation and LIS interlocking with Seegene Viewer

  • Whole process validation

    Whole process validation from extraction to PCR by whole process control

  • Powerful performance

    PCR with high sensitivity and specificity

  • Analytes

    Allplex™
    SARS-CoV-2 Variants I Assay

    • E484K (S gene)
    • HV69/70 deletion (S gene)
    • N501Y (S gene)
    • SARS-CoV-2 (RdRP gene)
    • Internal Control (IC)

  • Specimens

    • Sputum
    • Nasopharyngeal swab
    • Nasopharyngeal aspirate
    • Bronchoalveolar lavage
    • Oropharyngeal swab
    • Saliva
    • Combo-swab (nasal swab+oral swab)

  • Ordering Information

    Product
    Cat No. / Size
    Allplex™ SARS-CoV-2 Variants I Assay
    RV10381Z / 25 rxns [1]
    RV10286X / 100 rxns [2]

Result


Publication

- SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021

Note

[1]

[2] For use with Seegene NIMBUS & STARlet only